Aperio Group’s Asensus Surgical, Inc. ASXC Stock Holding History

Aperio Group’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-25	Closed	–	–	2814
2019 Q2	$0	Buy	+25	New	+$547	﹤0.01%	3048

Other funds holding ASXC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return

Aperio Group's ASXC Position: Q3 2019 in Review

Aperio Group sold out of Asensus Surgical, Inc. (ASXC) in Q3 2019, closing a stake of 25 shares.

Aperio Group first reported a position in ASXC in Q2 2019 and held it in 1 quarter. The position peaked at $0 in Q2 2019. 130 funds tracked by Wall St. Rank hold ASXC as of Q3 2019.

Aperio Group reported no remaining Asensus Surgical, Inc. position as of Q3 2019 after selling out during the quarter.
Aperio Group sold 25 Asensus Surgical, Inc. shares in Q3 2019.
Aperio Group first reported a position in Asensus Surgical, Inc. in Q2 2019 and held it in 1 quarter.
Aperio Group's Asensus Surgical, Inc. position peaked at $0 in Q2 2019.
130 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2019.

Based on Aperio Group's 13F filing for Q3 2019, filed 6 Nov 2019.